MARKET

QLGN

QLGN

Qualigen Therapeutics Inc
NASDAQ
0.2476
-0.0051
-2.02%
Opening 12:56 07/26 EDT
OPEN
0.2670
PREV CLOSE
0.2527
HIGH
0.2700
LOW
0.2360
VOLUME
381.41K
TURNOVER
0
52 WEEK HIGH
1.260
52 WEEK LOW
0.1449
MARKET CAP
2.82M
P/E (TTM)
-0.1110
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at QLGN last week (0715-0719)?
Weekly Report · 4d ago
Why Match Group Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Match Group, Inc. Shares jumped 8% in today's pre-market trading. The online dating company's shares jumped around 6.5% on Monday. Starboard Value has taken a keen interest in Match Group and is advocating for a sale. Conduit Pharmaceuticals Inc. And Trump Media & Technology Group Corp. Were among the stocks moving in pre- market trading.
Benzinga · 07/16 09:51
3 Penny Stocks to Watch Now, 7/16/24
TipRanks · 07/16 05:18
Why SolarEdge Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
SolarEdge Technologies, Inc. Shares dipped 12.2% to $27.77 on Monday after the company announced a workforce reduction. Trump Media & Technology Group Corp. Shares rose 32.8% following the attempted assassination of Donald Trump. Shares of prison and firearm stocks traded higher following the attack.
Benzinga · 07/15 17:23
Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Falls In July
The Dow Jones index gained more than 200 points on Monday. Information technology shares jumped by 1.1% in trading. The NY Empire State Manufacturing Index fell to a reading of -6.6 in July, compared to market estimates of -7.0. Asian markets closed mixed on Monday with the NASDAQ rising 0.52% and the S&P 500 up 0.44%.
Benzinga · 07/15 13:47
Why Is Moolec Science (MLEC) Stock Down 18% Today?
Shares of Moolec Science (MLEC) stock are down 17.5% as of Monday morning. The company announced a three-year supply agreement for its GLASO nutritional oil product. Qualigen Therapeutics (QLGN) stock, Trump Media & Technology (DJT) stock and DatChat (DATS) are also down on Monday.
Investorplace · 07/15 12:33
Why Is Qualigen Therapeutics (QLGN) Stock Down 22% Today?
Qualigen Therapeutics (NASDAQ:QLGN) stock is falling on Monday after a massive rally on Friday. The clinical-stage therapeutics company's shares closed up 109.2% on Friday after securing new funding. QLGN stock is down 21.9% as of Monday morning. Trump Media & Technology (DJT) and DatChat (DATS) are the biggest pre-market movers.
Investorplace · 07/15 12:19
Weekly Report: what happened at QLGN last week (0708-0712)?
Weekly Report · 07/15 11:54
More
About QLGN
Qualigen Therapeutics, Inc. is a clinical-stage therapeutics company. The Company is focused on developing treatments for adult and pediatric cancers. The Company’s business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program (Pan-RAS). Its lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells (such as pancreatic cancer). Its Pan-RAS program, which is at the preclinical stage, consists of a family of rat sarcoma virus (RAS) oncogene protein-protein interaction inhibitor small molecules inhibits or block mutated RAS genes’ proteins from binding to their effector proteins thereby leaving the proteins from the mutated RAS unable to cause further harm. Its QN-302 is in a Phase 1a clinical trial.

Webull offers Qualigen Therapeutics Inc stock information, including NASDAQ: QLGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, QLGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading QLGN stock methods without spending real money on the virtual paper trading platform.